StockData
Rockwell Medical, Inc. logo

Rockwell Medical, Inc. (RMTI) stock

RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)

Close on Nov 17, 2026Market cap $26.64MP/E –Yield –

Rockwell Medical profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Rockwell Medical's profit margin for the twelve months ending Jun 30, 2026 was -7.3%. For fiscal 2025 it was -7.7%, against -0.5% the year before. The highest annual figure on record is -0.5% in fiscal 2024.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-7.7%−7.2
FY2024Dec 31, 2024-0.5%+9.6
FY2023Dec 31, 2023-10.1%+15.6
FY2022Dec 31, 2022-25.7%+27.1
FY2021Dec 31, 2021-52.8%−3.1
FY2020Dec 31, 2020-49.7%+6.0
FY2019Dec 31, 2019-55.7%−5.0
FY2018Dec 31, 2018-50.7%−5.4
FY2017Dec 31, 2017-45.2%−8.1
FY2016Dec 31, 2016-37.2%−11.1
FY2015Dec 31, 2015-26.1%+13.3
FY2014Dec 31, 2014-39.4%+53.8
FY2013Dec 31, 2013-93.1%+15.3
FY2012Dec 31, 2012-108.4%−64.6
FY2011Dec 31, 2011-43.8%−39.3
FY2010Dec 31, 2010-4.5%+5.5
FY2009Dec 31, 2009-10.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-6.6%+2.7
Q1 FY2026Mar 31, 2026-9.3%−1.2
Q4 FY2025Dec 31, 2025-3.0%+0.0
Q3 FY2025Sep 30, 2025-11.0%−16.9
Q2 FY2025Jun 30, 2025-9.3%−10.6
Q1 FY2025Mar 31, 2025-8.0%−0.4
Q4 FY2024Dec 31, 2024-3.1%+3.8
Q3 FY2024Sep 30, 20245.9%+13.8
Q2 FY2024Jun 30, 20241.3%+19.6
Q1 FY2024Mar 31, 2024-7.6%+1.3
Q4 FY2023Dec 31, 2023-6.8%+5.4
Q3 FY2023Sep 30, 2023-7.9%+14.5
Q2 FY2023Jun 30, 2023-18.3%+8.3
Q1 FY2023Mar 31, 2023-8.9%+35.5
Q4 FY2022Dec 31, 2022-12.2%+46.1
Q3 FY2022Sep 30, 2022-22.4%+25.0
Q2 FY2022Jun 30, 2022-26.6%+28.9
Q1 FY2022Mar 31, 2022-44.4%+5.7
Q4 FY2021Dec 31, 2021-58.3%−1.2
Q3 FY2021Sep 30, 2021-47.4%+0.7
Q2 FY2021Jun 30, 2021-55.5%−12.1
Q1 FY2021Mar 31, 2021-50.1%+0.2
Q4 FY2020Dec 31, 2020-57.1%−10.0
Q3 FY2020Sep 30, 2020-48.1%+2.9
Q2 FY2020Jun 30, 2020-43.4%+26.0
Q1 FY2020Mar 31, 2020-50.4%+5.4
Q4 FY2019Dec 31, 2019-47.1%+8.5
Q3 FY2019Sep 30, 2019-51.0%−21.2
Q2 FY2019Jun 30, 2019-69.3%+12.7
Q1 FY2019Mar 31, 2019-55.8%−18.7
Q4 FY2018Dec 31, 2018-55.6%+5.3
Q3 FY2018Sep 30, 2018-29.8%+4.8
Q2 FY2018Jun 30, 2018-82.0%−28.5
Q1 FY2018Mar 31, 2018-37.1%−4.6
Q4 FY2017Dec 31, 2017-60.9%−23.2
Q3 FY2017Sep 30, 2017-34.6%+1.0
Q2 FY2017Jun 30, 2017-53.5%–
Q1 FY2017Mar 31, 2017-32.5%–
Q4 FY2016Dec 31, 2016-37.7%–
Q3 FY2016Sep 30, 2016-35.6%–

More Rockwell Medical figures

See a number that looks wrong?